Cargando…
MicroRNAs: emerging biomarkers and therapeutic targets of bone fragility in chronic kidney disease
Bone fragility is highly prevalent, yet underdiagnosed in patients with chronic kidney disease. Incomplete understanding of the pathophysiology and limitations of current diagnostics contribute to therapeutic hesitation, if not nihilism. This narrative review addresses the question of whether microR...
Autores principales: | Smout, Dieter, Van Craenenbroeck, Amaryllis H, Jørgensen, Hanne Skou, Evenepoel, Pieter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972833/ https://www.ncbi.nlm.nih.gov/pubmed/36865016 http://dx.doi.org/10.1093/ckj/sfac219 |
Ejemplares similares
-
Isolating mineralized bone and bone marrow mRNA from transiliac bone biopsies stored in a stabilizing solution: A comparative study
por: de Loor, Henriette, et al.
Publicado: (2022) -
Exercise training in patients after kidney transplantation
por: De Smet, Stefan, et al.
Publicado: (2021) -
Management of fracture risk in CKD—traditional and novel approaches
por: Haarhaus, Mathias, et al.
Publicado: (2022) -
The new Clinical Kidney Journal, 4 years later
por: Ortiz, Alberto, et al.
Publicado: (2019) -
Parathyroidectomy Versus Calcimimetic: The Lower the PTH the Better?
por: Evenepoel, Pieter, et al.
Publicado: (2022)